Active Ingredient: ARGATROBAN
Proprietary Name: ARGATROBAN IN SODIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022434
Product Number: 001
Approval Date: Jun 29, 2011
Applicant Holder Full Name: CIPLA LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
